Sir Run Run Shaw Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

5 drugs in development

Phase 31

Phase 23

Phase 11

Preclinical1

By Therapeutic Area

top 1

Oncology

5100%

R&D Momentum

58/100

Pipeline Velocity

25/100

Trial Completion Rate

100/100

Pipeline Concentration

100/100

Pipeline Freshness

57/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners

Activity

Recent Activity

Last 14 days

Jul 2, 2026

Enrolling by invitation

Left Atrial Appendage Closure and Pulsed Field Ablation Procedure Versus Left Atrial Appendage Closure Alone in Persistent Atrial Fibrillation Patients With Mild Symptoms and High Risk of Stroke: A Prospective, Multicenter, Single-Blind, Randomized Controlled Pilot Study

Jul 1, 2026

Active, not recruiting

Node-sparing Modified Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Locally Advanced of Middle and Low Rectal Cancer : An Randomized, Prospective, Multicenter, Open-label, Phase III Clinical Trial (mRCAT-III)

Earlier

Dec 25, 2025TrialReal-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Dec 1, 2025TrialStudy on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Oct 9, 2025TrialNode-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer

Aug 20, 2025TrialThe Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)

Jul 3, 2025TrialExploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma

Jun 1, 2025TrialEarly Endovascular Treatment in Isolated Internal Carotid Artery Occlusion

3 more events

May 1, 2025TrialThe Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

Apr 1, 2025TrialIcaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

Apr 1, 2025TrialShort-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer

Details